NABL Certified Labs

Book CEA Test in Dehradun

35+ Regional Processing Labs
4500+ Serviceable Pincodes across India
75000+ Samples Processed Daily

Test Price

₹820

Book Now
Free Home Collection Reports in 24 Hrs

Quick Carcino Embryonic Antigen Test Overview in Dehradun

Also Known As Carcinoembryonic Antigen Test, CEA Tumour Marker Test
Sample Type Blood (Venous)
Fasting Required No
Report Delivery Within 24 hours
Age Group All age groups
Gender All
Test TypeTest Type Electrochemiluminescence Immunoassay (ECLIA)
Units ng/mL (nanograms per millilitre)
1

The CEA test is a blood test that measures the level of Carcinoembryonic Antigen, a protein normally produced in very small amounts by the body. CEA is classified as a tumour marker, a substance whose levels rise significantly in the presence of certain cancers, particularly colorectal cancer. During foetal development, CEA is produced in large quantities, but production drops to very low levels after birth. In adults, abnormally elevated CEA levels in the blood signal that certain cancer cells may be producing it in excess. CEA is most strongly associated with colorectal cancer and is the most widely used tumour marker for monitoring treatment response and detecting recurrence in patients diagnosed with colon or rectal cancer. It is also elevated in cancers of the lung, breast, stomach, pancreas, ovary, and thyroid. In India, colorectal cancer incidence is rising steadily alongside changing dietary patterns and increasing rates of obesity, making CEA an increasingly important diagnostic and monitoring tool. It is critical to understand that CEA is not a screening test for cancer in the general population as it can be elevated in several non-cancerous conditions. Its greatest clinical value lies in post-diagnosis monitoring and recurrence detection. The test involves a simple blood draw completed in under five minutes.
2

Doctors prescribe a CEA test in the following situations: Monitoring treatment response in patients diagnosed with colorectal cancer undergoing surgery, chemotherapy, or radiation therapy, where a falling CEA confirms that treatment is effective and tumour burden is reducing. Detecting colorectal cancer recurrence after curative surgery, where a rising CEA during post-operative follow-up is often the earliest indicator of recurrence, frequently preceding symptoms or imaging findings by several months. Staging and pre-operative assessment in newly diagnosed colorectal cancer patients, where the baseline CEA level before surgery provides prognostic information and helps guide surgical and oncological planning. Monitoring other CEA-producing cancers including lung, breast, gastric, pancreatic, and ovarian cancers in patients already under oncological care, where serial CEA measurements track disease progression or response to therapy. Investigating a suspected recurrence or disease progression in cancer patients who develop new symptoms, abnormal imaging findings, or unexplained weight loss during follow-up. Evaluating patients with a strong family history of colorectal cancer or known hereditary colorectal cancer syndromes such as Lynch syndrome or familial adenomatous polyposis as part of a broader surveillance strategy alongside colonoscopy.
3

The CEA test measures the concentration of Carcinoembryonic Antigen in the blood, reported in nanograms per millilitre (ng/mL). Normal CEA Range in India The standard reference ranges used across most Indian diagnostic laboratories and oncology centres are as follows. For non-smokers, a CEA level below 3.0 ng/mL is considered normal. For smokers, the upper limit of normal is slightly higher at below 5.0 ng/mL, as smoking independently elevates CEA levels. Interpreting CEA Results A CEA level between 3.0 and 10.0 ng/mL represents a mild to moderate elevation. At this level, non-cancerous causes including liver disease, inflammatory bowel disease, pancreatitis, and smoking must be considered alongside malignancy before any conclusion is drawn. A CEA level above 10.0 ng/mL is considered significantly elevated and raises stronger concern for an underlying malignancy, particularly colorectal cancer, and warrants urgent further investigation including imaging and endoscopy. A CEA level above 20.0 ng/mL in a patient with known or suspected cancer is highly indicative of active or metastatic disease and requires immediate oncological evaluation. In monitored cancer patients, the trend of CEA over serial measurements is more clinically important than any single value. A consistently rising CEA during follow-up, even within the normal range, warrants investigation for recurrence.
4

No fasting is required for the CEA test. You can eat and drink normally before sample collection. Our team confirms preparation requirements at the time of booking. Inform your doctor and the phlebotomist if you are a smoker, as smoking independently raises CEA levels and a higher normal reference range applies to smokers. Ideally, avoid smoking for several hours before sample collection for the most representative baseline. Inform the phlebotomist about all medications, chemotherapy agents, and hormonal therapies you are currently taking, as these can influence CEA levels and must be disclosed for accurate interpretation. Avoid scheduling the CEA test during or immediately after an acute illness, active infection, or significant inflammatory condition, as transient CEA elevations can occur in these states and may complicate interpretation. Stay normally hydrated before sample collection.
5

If you are booking through SecondMedic platform the CEA test price in Dehradun can cost you around Rs. 820. The exact price for your CEA test in Dehradun will be confirmed at the time of booking through SecondMedic. If your doctor has prescribed multiple tests alongside CEA, SecondMedic health packages available in Dehradun include CEA as part of a broader tumour marker or oncology monitoring panel at a significantly lower combined price.
6

SecondMedic provides home sample collection for CEA test across all major areas of Dehradun. You do not need to visit a lab or collection centre. A certified and trained phlebotomist comes to your home or workplace at your chosen time, collects the sample using sterile single-use equipment, and ensures it is transported to the NABL-accredited lab within the required time window for accurate processing. Please note that SecondMedic provides free home sample collection on all tests priced above Rs. 300. Our team will check your pincode and confirm if your address in Dehradun falls under our free sample collection eligibility criteria, which depends upon the lab location and phlebotomist availability. Home collection in Dehradun is available between 7 AM and 10 PM, seven days a week, including Sundays and public holidays. Enter your pincode on the booking page or call our helpline to confirm availability at your address in Dehradun.

Our Presence In India

People Also Ask

Yes, CEA test is available in Dehradun through SecondMedic with home collection and walk-in options. As a key oncology tumour marker for colorectal and other cancers, SecondMedic ensures CEA testing is accessible across all major serviceable areas in Dehradun with NABL-accredited processing.

If you are booking through SecondMedic platform the CEA test price in Dehradun can cost you around Rs. 820. The exact price will be confirmed at the time of booking and may vary if booked as part of a broader tumour marker or oncology monitoring panel.

Your CEA report will be delivered within 24 hours of sample collection in Dehradun directly on WhatsApp and email. No physical visit to any centre in Dehradun is required to collect the report.

All CEA samples collected in Dehradun are processed at NABL-accredited partner laboratories using validated electrochemiluminescence immunoassay methods. Accurate CEA measurement is critical as colorectal cancer recurrence detection and treatment response decisions are directly based on serial CEA values.

Yes, SecondMedic provides home sample collection for CEA test across all major areas of Dehradun. No fasting is required and you can eat and drink normally before the visit. This is particularly valuable for cancer patients undergoing active treatment or post-surgical monitoring who benefit from avoiding unnecessary travel.

Yes, home collection for CEA test in Dehradun is available on Sundays and all public holidays between 7 AM and 10 PM. Cancer patients on regular oncology follow-up schedules can book any day without scheduling constraints.

CEA test is prescribed primarily to monitor treatment response and detect recurrence in colorectal cancer patients after surgery or chemotherapy. It is also used in the follow-up of lung, breast, gastric, and pancreatic cancers and as part of pre-operative staging in newly diagnosed colorectal cancer where the baseline CEA level carries prognostic significance.

A CEA level below 3.0 ng/mL is normal for non-smokers and below 5.0 ng/mL for smokers. Levels above 10.0 ng/mL warrant urgent further investigation and levels above 20.0 ng/mL in a known cancer patient are highly suggestive of active or metastatic disease requiring immediate oncological evaluation.

An elevated CEA above the normal range in a patient with known colorectal or other cancer indicates possible disease progression, treatment failure, or recurrence and requires urgent oncological review. A rising CEA trend during post-surgical follow-up, even within normal limits, is a clinically significant finding that warrants imaging and endoscopic reassessment for early detection of recurrence.

Content Reviewed By

Reviewer
Reviewed by:

Dr. Kovid Pandey

MBBS, General Physician

Last Reviewed: 10th Mar 2026

References

1
Duffy MJ et al.: Use of Tumour Markers in Gastrointestinal Cancers: European Group on Tumour Markers Recommendations, European Journal of Cancer, 2010 — pubmed.ncbi.nlm.nih.gov
2
National Comprehensive Cancer Network: NCCN Guidelines for Colon Cancer, NCCN, 2023 — www.nccn.org
3
Locker GY et al.: ASCO 2006 Update of Recommendations for the Use of Tumour Markers in Gastrointestinal Cancer, Journal of Clinical Oncology, 2006 — pubmed.ncbi.nlm.nih.gov
4
Indian Council of Medical Research: Consensus Document for Management of Colorectal Cancer, ICMR, 2014 — www.icmr.gov.in
5
Goldstein MJ, Mitchell EP: Carcinoembryonic Antigen in the Staging and Follow-up of Patients with Colorectal Cancer, Cancer Investigation, 2005 — pubmed.ncbi.nlm.nih.gov

Download Our App & Get Consultation from anywhere.

App Download